![]() The global Omics Lab Services Market size is expected to reach USD 194.04 billion by 2030, registering CAGR of 13.72% during the forecast period, according to a new report by Grand View Research, Inc. The development of the market is attributed to growing integration of the genomics data into clinical workflow and rising adoption of direct-to-consumer omics. Moreover, rising demand for early disease diagnostic test, technological advancements aided with increasing government funding is further propelling growth of the overall market. Growing recognition of omics' potential in human disease management and other nonconventional applications has fueled the implementation of omics data. This, in turn, has increased competition among firms to introduce products and technologies by leveraging available genetic information, capitalizing on the ample growth avenues in the market. Advanced laboratory analytics also support the development of precision and personalized medicine, which has an influence beyond general patient care. Thorough progress has already been made in the field of oncology, and developments in omics and single-cell micro technology have greatly benefited progress toward upcoming patient-centered approach. Moreover, the field of oncology has benefited most from omics research, and one newly developed use of NGS clinical tests is for the quantification of circulating tumor DNA (ctDNA) from plasma. Numerous NGS technologies, such as Cancer Personalized Profiling by deep Sequencing, may be used. High-throughput RNA sequencing developments have brought light the importance of transcriptomics in biological and clinical research. RNA sequencing using NGS technologies or microarrays are two ways to perform transcriptomics. Proteomics and metabolomics are two domains that have been significantly characterized by improvements in NMR and MS technologies. Furthermore, key players operating in the market are focusing on incorporating omics technology in early diagnosis. For instance, in May 2021, Burning Rock Biotech Limited launched PRESCIENT, first pan cancer, multi omics early detection study in China. In March 2022, PrognomiQ invested USD 46.0 million in advancing development of multiomics for early detection of cancer. In September 2022, Bertis launched Proteomic based research of its new biomarkers for diagnosis of ovarian cancer. Moreover, in July 2022, Mission Bio, Inc. launched Tapestri platform for single cell multiomics-based MRD detection in blood cancers. These initiatives and research in the field of omics for the development of early diagnosis tools is further propelling the overall omics labs services market growth. Related Press Release@ Omics Lab Services Market Report Omics Lab Services Market Report Highlights
Related Reports@ Lab Automation Market Central Lab Market Omics Lab Services Market Report ScopeReport Attribute Details Market size value in 2023 USD 79,904.95 million Revenue forecast in 2030 USD 194.04 billion Growth rate CAGR of 13.72% from 2023 to 2030 Base year for estimation 2022 Historical data 2018 - 2021 Forecast period 2023 - 2030 Omics Lab Services Market Segmentation Grand View Research has segmented the global omics lab services market report based on the services, business, frequency of service, product, end-use, and region: Omics Lab Services Services Outlook (Revenue, USD Million, 2018 - 2030)
0 Comments
![]() The global Pharmaceutical CDMO Market size is expected to reach USD 232.587 billion by 2030, registering a CAGR of 6.1% over the forecast period, according to a new report by Grand View Research, Inc. increasing demand for biologics, growing outsourcing of drug development and manufacturing activities, and rising investments in research and development (R&D) by pharmaceutical and biotechnology companies as key drivers of market growth. Additionally, the report highlights the emergence of small and mid-sized pharma and biotech companies and the shift towards personalized medicine as further factors expected to drive the market forward. The rising demand for biologics, in particular is anticipated to significantly contribute to the expansion of the CDMO industry. The use of these complex molecules created by living things in the treatment of many ailments is becoming more and more crucial. Because many pharmaceutical and biotechnology companies lack the specific manufacturing capabilities needed for biologics, medication research, and manufacturing processes are increasingly being outsourced. Pharmaceutical and biotech firms are turning to CDMOs to assist lower costs and increase efficiency as the cost of drug development and production keeps rising. The market for CDMOs is expanding because of a number of developments, including the expansion of small and mid-sized pharma and biotech firms, the trend toward personalized medicine, and the rising need for biologics. The COVID-19 pandemic provides a recent illustration of the demand for CDMO services. Several businesses lack the specific knowledge and manufacturing capabilities needed to develop and produce COVID-19 vaccines and treatments. As a result, some pharmaceutical firms have enlisted CDMOs' assistance in the development and manufacturing of vaccines and treatments. For instance, Moderna, a biotech company, partnered with Lonza, a CDMO, to manufacture its COVID-19 vaccine. This partnership allowed Moderna to significantly increase its manufacturing capacity and produce millions of vaccine doses in a short amount of time, helping to address the urgent need for COVID-19 vaccines. This example highlights the important role that CDMOs play in drug development and manufacturing and how they are helping to address critical global health challenges. Related Press Release@ Pharmaceutical CDMO Market Report Pharmaceutical CDMO Market Report Highlights
Nutraceuticals CDMO Market Healthcare Contract Development And Manufacturing Organization Market Pharmaceutical CDMO Market Segmentation Grand View Research has segmented the global pharmaceutical CDMO market based on product, workflow, application, and region: Pharmaceutical CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Population Screening Market size is expected to reach USD 38.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.36% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of diseases, the growing geriatric population, and increasing investment in population screening tests. Moreover, the market is expected to be driven significantly by increasing technological advancements and developments in these tests. An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases. The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market. Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes. Related Press Release@ Population Screening Market Report List of Key Players in Population Screening Market
Details Market size value in 2023 USD 25,715.15 million Revenue forecast in 2030 USD 38.2 billion Growth rate CAGR of 5.36% from 2023 to 2030 Base year for estimation 2022 Historical data 2018 - 2021 Forecast period 2023 - 2030 Related Reports@ Cellular Health Screening Market Blood Screening Market Population Screening Market Segmentation Grand View Research has segmented the global population screening market based on geography, product, business, gender, type, age, and region: Population Screening Geography Outlook (Revenue, USD Million, 2018 - 2030)
The global External Urine Management Products Market size is anticipated to reach USD 844.37 million by 2030, registering a CAGR of 5.09% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of Urinary Incontinence (UI), along with the need for effective and long-term solutions for the management of UI is anticipated to boost the market growth. An increasing number of incontinent patients is expected to boost the demand for external urine management products, thereby boosting the market growth during the forecast period. For instance, according to Phoenix Physical Therapy, over 200 million people are affected with urinary incontinence worldwide. Women are more susceptible to UI as compared to men due to hormonal changes, pregnancy, or menopause.
Rising initiatives by several market players to raise awareness regarding incontinence care globally are successfully breaking the stigma and taboo associated with it. For instance, the World Federation of Incontinence Patients (WFIP) introduced an annual initiative called World Continence Week with the approval of the International Incontinence Society. This initiative has been started at the global level to spread awareness related to UI, bladder weakness, and other conditions.Moreover, the outbreak of the COVID-19 has spurred the demand for incontinence products, such as external urinary catheters used in home settings. Since most consumers are aged/seniors, there is a higher demand for these products. Restrictions on movement at international borders have created an opportunity for local players to enter the market and meet the unmet demands of the end-users. Related Press Release@ External Urine Management Products Market Report External Urine Management Products Market Report Highlights
Urinary Catheters Market Women's Health Rehabilitation Products Market External Urine Management Products Market Report Scope Report Attribute Details Market size value in 2022 USD 567.59 million Revenue forecast in 2030 USD 844.37 million Growth rate CAGR of 5.09% from 2022 to 2030 Base year for estimation 2021 Historical data 2018 - 2020 Forecast period 2022 - 2030 External Urine Management Products Market Segmentation Grand View Research has segmented the global external urine management products market based on product, distribution channel, end-use, and region: External Urine Management Product Outlook (Revenue, USD Million, 2018 - 2030)
Insulin Market by Eli Lilly and Company; Sanofi; Novo Nordisk A/S; Biocon; Boehringer Ingelheim7/20/2023 ![]() The global Insulin Market is expected to reach USD 23.20 billion by 2030, expanding at a CAGR of 1.5% during the forecast period, according to a new report by Grand View Research, Inc. It is an oligopolistic space dominated by companies such as Novo Nordisk A/S, Sanofi, and Eli Lilly and Company. The increasing incidence of diabetes and formulation advancements in insulin delivery are the primary factors driving growth. However, the presence of biosimilars and drugs such as GLP-1 RAs for the treatment of type 2 diabetes can slow down market growth to a certain extent. Diabetes is one of the fastest-growing chronic diseases in the world. Its prevalence has increased steadily over the past few decades. The prevalence of the disease is growing rapidly in low- and middle-income countries; three in four adults live with diabetes in these countries. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. In addition, the increase in geriatric and obese populations is another factor driving growth. The overweight population is at risk of developing type 2 diabetes mellitus. According to WHO, in 2020, 1.9 billion adults were found to be overweight, accounting for 39% of the population within that age group. Formulation advancements in insulin delivery systems are being developed, the release of which is likely to propel the market over the forecast period. In December 2019, Tandem Diabetes Care’s Control-IQ, an interoperable device, received FDA authorization for marketing in the U.S. It is an automated insulin dosing algorithm that can be used with other interoperable devices. The top three manufacturing companies, Eli Lilly and Company, Novo Nordisk A/S, and Sanofi, hold a monopoly. These companies hold more than 90% of the market share. Owing to the oligopolistic nature of the market and patent protection, the cost of insulin is high. Hence, the high cost of products could impede industry growth. The COVID-19 pandemic caused a detrimental impact on the industry. Individuals with chronic illnesses, such as diabetes, have experienced substantial disruptions in emergency and routine medical care. According to an NCBI article, out of ~30 million diabetic patients in America, about 7.5 million are dependent on insulin. Insulin rationing or hoarding has already been a rampant issue, which increased further amid the pandemic due to supply concerns. However, in several countries, the effect of COVID-19 declined to post the third quarter of 2020, which helped the market regain traction. Related Press Release@ Insulin Market Report Insulin Market Report Highlights
Insulin Pump Market Insulin Storage Devices Market Insulin Market Segmentation Grand View Research has segmented the global Insulin market based on product type, application, type, distribution channel, and regions: Insulin Product Type Outlook (Revenue, USD Million, 2018 - 2030)
The global Unilateral Biportal Endoscopy Market size is expected to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2022 to 2030. Increasing demand for minimally invasive surgeries and the growing awareness of the benefits such as reduced hospitalization, minimal collateral tissue damage, reduced postoperative complications, and faster recovery. Moreover, surgeons and their practices are transitioning from conventional open procedures to robotic assisted and visually advanced endoscopic procedures. Furthermore, technology advancements in the field of spinal endoscopic procedures and minimally invasive surgeries are expected to bolster market growth. For instance, June 2017, Olympus introduced 3D surgical endoscope, which is compatible with VISERA ELITE II system. It uses 3D imaging that helps with in depth perception for precision in surgery.
The on-going Covid-19 pandemic has burdened healthcare systems across the globe and has led to significant transformations in the healthcare industry, thereby forcing endoscopy facilities to reduce volumes of elective and non-essential endoscopic procedures. For instance, a survey conducted for endoscopy units across 55 countries by the World Endoscopy Organization between April 2020 and May 2020, reported an 87.0% reduction of in the number of endoscopy procedures. The ongoing pandemic has caused alterations in the operating room structures, workforce, indications, and pre-op setup. The alarming decline in endoscopic procedures was recorded in emerging economies with developing healthcare facilities. In 2021, the reusable product type segment accounted for the largest revenue share owing to the widespread adoption of these products due to their recoverability rate through disinfection and sterilization. The bifurcation of these products based on the exposure of infection risk into critical, semi-critical, and non-critical devices enables selecting the appropriate disinfection process. On the other hand, single use product type segment is anticipated to register the fastest growth during the forecast period owing to the increasing incidence of hospital acquired infections due to reusable products. In addition, single use products are low on maintenance cost and storage, which is expected to propel the growth of this segment. Lastly, this product segment is witnessing a rise in adoption levels to curb the incidences of cross-contamination. Based on the application, the decompression segment accounted for the highest revenue share in 2021 owing to its minimally invasive nature and enhanced visualization of discs and nerves is contributing to the growth of this segment. The various forms of decompression procedures provide more favorable outcomes and minimum complications, thereby boosting growth. In addition to decompression techniques available for varied indications, degenerative lumbar canal stenosis recorded the highest revenue share in 2021 owing to the multiple benefits of decompression procedures such as prevention of paraspinal muscle atrophy, reduced muscle dissection, and retraction. Based on end-user, the hospitals segment accounted for the largest revenue share in 2021 owing to large-scale adoption of these endoscopic procedures and growing demand for minimally invasive surgeries. On the other hand, ambulatory surgery centers/clinics are anticipated to be the fastest growing segment during the forecast period owing to increasing preference for minimally invasive surgeries and reduced hospitalization. The growing trend of same day surgery has resulted in significant cost savings and optimum care delivery in the developed economies and is therefore expected to boost segment growth. In 2021, North America dominated the market. This can be attributed to developed healthcare infrastructure, high adoption of advanced technologies, and an increase in awareness about the advantages of minimally invasive therapies. On the other hand, Asia Pacific is expected to be the fastest-growing region during the forecast period owing to increasing investments by market players for geographic expansion and rapid economic development in countries such as China and India and improving health infrastructure in this region. Moreover, the prevalence of spinal disorders in the geriatric population is the highest in this region due to the presence of largest proportion of the geriatric population. Related Press Release@ Unilateral Biportal Endoscopy Market Report List of Key Players in Unilateral Biportal Endoscopy Market
Endoscopy Devices Market Endoscopy Visualization Systems Market Unilateral Biportal Endoscopy Market Segmentation Grand View Research, Inc. has segmented the global unilateral biportal endoscopy market report on the basis of product, application, end-user, and region: Unilateral Biportal Endoscopy Product Outlook (Revenue, USD Million, 2014 - 2030)
![]() The global Pharmaceutical Stability & Storage Services Market size is expected to reach USD 4.4 billion by 2030, registering a CAGR of 5.6% from 2022 to 2030, according to a new report by Grand View Research, Inc. Stability and storage is a mandatory regulation in various regions. For instance, different regulatory authorities have different data requirements and testing rules for testing stability. Even though FDA and EMA follow the ICH guidelines for stability testing, they still have different microbiological limits for stability tests. This has improved the demand for stability testing outsourcing services and is likely to have a positive impact on the market. The COVID-19 pandemic had increased the demand for COVID-19 vaccines globally. The growing vaccine drive by the government authorities is likely to drive the demand for stability and storage of commercial COVID-19 vaccines. In recent years pharmaceutical R&D spending has improved significantly. The growing R&D spending is expected to improve the number of drugs in the clinical stage. Stability testing is required for the approval of each phase of a clinical trial. This is further driving the market growth. Moreover, Biosimilar drugs are highly similar copies of biologics and are very cheaper, as compared to biologics. Biosimilar drugs are widely used in cancer, autoimmune diseases, and other diseases. This is contributing to the demand for biosimilar drugs and thereby is expected to drive the market demand. There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children’s National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in the disease incidence is expected to improve, drug production, which is likely to drive the market demand. Related Press Release@ Pharmaceutical Stability & Storage Services Market Report List of key players of Pharmaceutical Stability and Storage Services Market
Medical Transport Boxes Market Pharmaceutical Packaging Market Pharmaceutical Stability & Storage Services Market Report ScopeReport Attribute Details Market Size value in 2022 USD 2.8 billion Revenue forecast in 2030 USD 4.4 billion Growth Rate CAGR 5.6% from 2022 to 2030 Base year for estimation 2021 Historical data 2018 - 2020 Forecast period 2022 - 2030 Pharmaceutical Stability & Storage Services Market Segmentation Grand View Research has segmented the global pharmaceutical stability & storage services market on the basis of services, molecule, mode, and region: Services Outlook (Revenue, USD Million, 2018 - 2030)
The global Tendon Repair Market size is expected to reach USD 4.0 billion by 2030 and is expected to expand at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. Due to the aging population, increasing demand for minimally invasive procedures, and an increasing number of tendon-related injuries in sports and other events. Tendon injuries are prevalent during sports and physical training.
Soft tissue injuries such as sprains, strains, tendinitis, and contusions are common. These wounds can take a long time to heal, even with good treatment. Furthermore, the market is expected to develop due to the wear and tear of soft tissues in the geriatric population, which is caused by the weakening of connective tissues. Furthermore, as the number of accidents, particularly traffic accidents, rises, the demand for soft tissue procedures, such as tendon restoration, is likely to rise. In addition, one of the most prevalent shoulder ailments is rotator cuff tear. Over the forecast period, it is highly dynamic. Based on the product, the segment is divided into implants, suture anchor devices, grafts, scaffolds, screws, tendons repair matrix, and others. Due to the high frequency of rotator cuff injuries during exercise, rotator cuff repair had the largest revenue share of 40.4% in 2021 Such injuries are prevalent among athletes and sports players. According to figures published by Great Basin Orthopedics, around 200,000 people in the United States undergo rotator cuff surgery each year. This indicates the market's potential for growth. Furthermore, during the forecast period, the scaffolds category is expected to rise at a lucrative CAGR. Over the forecast period, the market for scaffolds is significantly increased due to increasing technical breakthroughs and product improvements. Based on the application, the segment is divided into rotator cuff repair, archilles tendinosis repair, cruciate ligament repairs, biceps tenodesis, and others. Due to the increased use of suture anchor devices in repair procedures, the suture anchor devices category accounted for the highest revenue share of 38.7% in 2021. Furthermore, product improvements that enhance the accuracy of these devices move the industry forward. Furthermore, the biceps tenodesis category is expected to increase at the highest rate, with a CAGR of 12.3 % during the projection period. Increased incidence and frequency of injuries, as well as the production or development of novel, innovative, and technologically advanced devices that are both patient-friendly and cost-effective, are expected to boost product adoption and thus market expansion. In 2021, North America had most of the market. Increased healthcare spending, improved healthcare infrastructure, and an increase in tendon injuries are expected to drive market expansion in the area. Due to the rising frequency of disorders needing tendon repair surgery in different nations across the area, Asia Pacific is expected to be the fastest-growing market during the forecast period, with a CAGR of 8.9 % in 2021. The COVID-19 pandemic has had a negative influence on the entire tendon restoration business, with surgical activity being reduced to avoid nosocomial contamination. Many hospitals have placed limits on all non-essential medical procedures as a result of the COVID-19 outbreak. The CDC and the American College of Surgeons (ACS) suggested postponing or canceling non-emergency surgical procedures in March 2020. While this measure was important for social safety, it had a great impact on millions of people around the world. Furthermore, due to the pandemic scenario in different parts of the world, orthopedic and tendon repair surgeries have been delayed. The COVID-19 pandemic, for example, caused a two-month delay in rotator cuff replacement treatments, according to a report published in JSES International. Related Press Release@ Tendon Repair Market Report List of Key Players of the Tendon Repair Market
Tendon Repair Market Report Highlights
Details Market size value in 2022 USD 2.2 billion Revenue forecast in 2030 USD 4.0 billion Growth Rate CAGR of 7.5% from 2022 to 2030 Base year for estimation 2021 Historical data 2016 - 2020 Forecast period 2022 - 2030 Related Reports@ Tendonitis Treatment Market Artificial Tendons and Ligaments Market Tendon Repair Market Segmentation Grand View Research, Inc. has segmented the global tendon repair market report based on product type, application, and region. Product Type Outlook (Revenue, USD Million, 2016 - 2030)
![]() The global Pipette Tips Market size is anticipated to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.0% over the forecast period. The rise in demand for advanced liquid handling systems is boosting the market growth. The rising incidence of newer medical conditions is increasing the requirement for more R&D efforts as well as the demand for advanced automated laboratory medical devices in countries, such as the U.S. and Canada, which is among the major factors driving the market growth. The introduction of automated and robotic pipettes and their growing use in pharma and biotech, diagnostics and healthcare, academics, and education industries are also expected to drive the market during the forecast period. The standard pipette product segment led the market in 2021 due to the multipurpose use and effectiveness of these products. A standard tip is a multi-purpose tip for many laboratory applications with a variety of performance requirements that range from high accuracy to reagent dispensing with greater tolerance. Sterile standard tips are available for applications demanding the highest level of purity. The demand for pipette tips escalated drastically in 2020 due to the COVID-19 pandemic as daily testing at diagnostic centers for virus detection increased. Even though there was a high demand, many companies faced operational and supply chain bottlenecks, which stabilized in 2021. The outbreak of COVID-19 fueled the need for extensive and effective development of vaccines and drugs as pharma and biotech industries are the major consumers of the market. Related Press Release@ Pipette Tips Market Report List of Key Players of Pipette Tips Market
Details Market size value in 2022 USD 677.15 million Revenue forecast in 2030 USD 1.3 billion Growth rate CAGR of 8.0% from 2022 to 2030 Base year for estimation 2021 Historical data 2018 - 2020 Forecast period 2022 - 2030 Related Reports@ Catheter Market Insulin Storage Devices Market Pipette Tips Market Segmentation Grand View Research has segmented the global pipette tips market based on product, technology, application, and region: Pipette Tips Product Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Therapeutic Contact Lenses Market size is expected to reach USD 7.08 billion by 2030, registering a CAGR of 7.13% from 2022 to 2030, according to a new report by Grand View Research, Inc. Therapeutic contact lenses can help repair tissue, manage pain, and maintain visual acuity, thereby surging its preference among individuals. Increasing adoption of therapeutic contact lenses among the developing economies after ocular surgery is estimated to surge the demand for therapeutic contact lenses. The increasing prevalence of glaucoma is anticipated to surge the demand for therapeutic contact lenses during the forecast period. For instance, as per the WHO, the number of people with glaucoma disorder is projected to rise from 76 million in 2020 to 95 million across the globe by 2030. Several researchers across the countries including China, U.K., and others are focusing on developing therapeutic smart contact lenses that will monitor eye pressure and treat glaucoma. Therapeutic lenses are used to manage a wide variety of corneal conditions including corneal erosions, corneal epithelial defects, bullous keratopathy, and postsurgical disorders such as post-laser vision correction and post-keratoplasty. Increasing application of therapeutic contact lenses in the treatment of eye disorders is anticipated to foster the overall market growth. The effects of the ongoing COVID-19 pandemic, as well as the mitigation measures, may continue to have a material adverse impact on the market. In initial 2020, almost every major market began to implement business shutdowns, including clinics of eye care professionals, and the delay of non-urgent surgical ophthalmic procedures, leading to a global economic stoppage. Such activities have caused disruptions to the operations, supply chain, facilities, and associate workforce, hindering the supply chain of medical devices including therapeutic contact lenses. Related Press Release@ Therapeutic Contact Lenses Market Report List of Key Players in Therapeutic Contact Lenses Market
Therapeutic Contact Lenses Market Report Highlights
Details Market size value in 2022 USD 4.08 billion Revenue forecast in 2030 USD 7.08 billion Growth rate CAGR of 7.13% from 2022 to 2030 Base year for estimation 2021 Actual estimates/Historic data 2017 - 2020 Forecast period 2022 - 2030 Related Reports@ Contact Lenses Market Myopia And Presbyopia Treatment Market Therapeutic Contact Lenses Market Segmentation Grand View Research has segmented the global therapeutic contact lenses market based on product type, application, distribution channel, and region: Therapeutic Contact Lenses Product Type Outlook (Revenue, USD Million; 2017 - 2030)
|
Archives
October 2023
|